Live feed18:30:05·171dINSIDERFilingvia QuantisnowPresident and CEO Oliveto Joseph was granted 280,000 shares, sold $375,315 worth of shares (167,577 units at $2.24) and converted options into 66,600 shares, increasing direct ownership by 59% to 482,744 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.MIST· Milestone Pharmaceuticals Inc.Health CareOriginal source
